Patterson Belknap Secures $43 Million Settlement in Fraud Suit on Behalf of Medical Device Manufacturer
March, 2021 - United States of America
In February, the Firm secured a settlement for our client, a multinational biotech company, in the U.S. District Court for the Northern District of Alabama. The suit accused the defendant, a group of pharmacies in Alabama, Mississippi, and Arkansas, of selling consumers thousands of boxes of our client’s blood glucose test strips that were not intended for retail sale. The defendant was also accused of receiving reimbursement for the higher cost of retail strips from healthcare insurers and pharmacy benefits managers. The terms of the $43 million settlement include a permanent injunction against the defendants that prohibits them from adjudicating, purchasing, selling, distributing or dispensing the client’s test strips.
